Skip to content

Ardelyx ARDX Work in process

Work in process at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
$98M-10.9%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$41.42M-0.8%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$31.08M+21.9%
Amgen logo
AmgenAMGN
AbbVie logo
AbbVieABBV
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:InventoryWorkInProcess.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's work in process.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's work in process?
Ardelyx (ARDX) reported work in process of $90.04M in Q1 2026.
How has Ardelyx's work in process changed year-over-year?
Ardelyx's work in process increased by 47.6% year-over-year, from $60.99M to $90.04M.
What is the long-term trend for Ardelyx's work in process?
Over 3 years (2022 to 2025), Ardelyx's work in process has grown at a 155.0% compound annual growth rate (CAGR), from $5.32M to $88.26M.
What does work in process mean?
Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.